We are live on ! Find out more
PAVMW

PAVmed Inc. Warrant
PAVMW

Delisted

PAVMW was delisted on the 28th of January, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in PAVmed Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $1K → $0 (-$1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Wolverine Asset Management
Illinois
– -$1K -9,035 Closed

PAVMW Hedge Fund Activity: Q1 2022 in Review

0 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q1 2022, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PAVMW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Wolverine Asset Management, exiting entirely with an estimated $1K sold.

  • 0 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q1 2022, down from 2 in Q4 2021.
  • Funds reported $0 of PAVmed Inc. Warrant stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Warrant positions in Q1 2022 and 2 closed out, a net change of -2 holders.
  • The largest PAVmed Inc. Warrant seller in Q1 2022 was Wolverine Asset Management, an estimated $1K sold.

Based on aggregated 13F filings for Q1 2022.